CHARLOTTESVILLE, VA – February 2, 2007 – Diffusion Pharmaceuticals LLC, a drug discovery and development company pioneering a revolutionary approach to treat life-threatening diseases, today announced that it has received a $0.5 million grant (N00014-07-C-0424) from the Office of Naval Research (ONR). The funds will be used to support the transition of the company’s lead [...]

Charlottesville, VA — March 1, 2005 — Diffusion Pharmaceuticals LLC, a company that discovers and develops novel small-molecule therapeutics, today announced that it has reached an agreement with the New Approaches to Brain Tumor Therapy CNS Consortium (NABTT) for a comprehensive clinical trials program to test Diffusion’s lead drug candidate, trans sodium crocetinate (TSC), as [...]

CHARLOTTESVILLE, VA — Tuesday, September 7, 2004 — Diffusion Pharmaceuticals, an early-stage pharmaceutical company which discovers and develops novel small-molecule therapeutics, today announced it has been awarded a $1 million appropriation in the FY 2005 Defense Budget, which President Bush signed last month. These funds are allocated for studies to advance its lead compound, trans [...]